Core Scientific, Inc. (CORZ)

Core Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	319.02	510.67	502.4	640.31	544.48
Revenue Growth (YoY)	-37.53%	1.65%	-21.54%	17.60%	802.66%
Cost of Revenue	281.12	389.6	378.94	631.91	305.62
Gross Profit	37.9	121.07	123.46	8.4	238.86
Selling, General & Admin	159.22	113.69	108.11	226.01	64.55
Research & Development	-	-	-	26.96	7.67
Other Operating Expenses	100.89	139.11	6.34	-1,954	-42.14
Total Operating Expenses	260.12	252.8	114.45	-1,701	30.08
Operating Income	-245.59	-142.07	8.96	-2,110	131.49
Interest Expense	3.28	-37.07	-86.24	-96.83	-44.35
Other Non-Operating Income (Expense)	-45.72	-1,258	-168.53	42.97	-21.43
Total Non-Operating Income (Expense)	-42.44	-1,295	-254.77	-53.86	-65.78
Pretax Income	-288.03	-1,437	-245.8	-2,163	63.08
Provision for Income Taxes	0.58	0.86	0.68	-17.09	15.76
Net Income	-288.62	-1,438	-246.49	-2,146	47.31
Net Income to Common	-288.62	-1,438	-246.49	-2,146	47.31
Shares Outstanding (Basic)	318	256	380	341	207
Shares Outstanding (Diluted)	318	256	380	341	233
Shares Change (YoY)	24.33%	-32.65%	11.51%	46.01%	48.03%
EPS (Basic)	-0.88	-4.87	-0.65	-6.30	0.23
EPS (Diluted)	-0.88	-4.87	-0.65	-6.30	0.20
Free Cash Flow	-450.75	-52.07	48.95	-178.79	-56.74
Free Cash Flow Per Share	-1.42	-0.20	0.13	-0.52	-0.24
Gross Margin	11.88%	23.71%	24.57%	1.31%	43.87%
Operating Margin	-76.98%	-27.82%	1.78%	-329.46%	24.15%
Profit Margin	-90.47%	-281.57%	-49.06%	-335.20%	8.69%
FCF Margin	-141.29%	-10.20%	9.74%	-27.92%	-10.42%
EBITDA	-165.41	-21.94	105.41	-1,883	164.86
EBITDA Margin	-51.85%	-4.30%	20.98%	-294.15%	30.28%
EBIT	-245.59	-142.07	8.96	-2,110	131.49
EBIT Margin	-76.98%	-27.82%	1.78%	-329.46%	24.15%
Effective Tax Rate	-0.20%	-0.06%	-0.28%	0.79%	24.99%

Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q